Cargando…

Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses

Non-steroidal anti-inflammatory drugs (NSAIDs), such as non-selective NSAIDs (nsNSAIDs) or selective cyclooxygenase-2 (COX-2) inhibitors, are commonly prescribed for arthritic pain relief in patients with osteoarthritis (OA), rheumatoid arthritis (RA), or ankylosing spondylitis (AS). Treatment guide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Datto, Catherine, Hellmund, Richard, Siddiqui, Mohd Kashif
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074787/ https://www.ncbi.nlm.nih.gov/pubmed/27790020 http://dx.doi.org/10.2147/OARRR.S41420

Ejemplares similares

Comparison of the pharmacokinetics and tolerability of HCP1004 (a fixed-dose combination of naproxen and esomeprazole strontium) and VIMOVO(®) (a marketed fixed-dose combination of naproxen and esomeprazole magnesium) in healthy volunteers
por: Choi, YoonJung, et al.
Publicado: (2015)

The RP-HPLC method for simultaneous estimation of esomeprazole and naproxen in binary combination
por: Jain, Deepak Kumar, et al.
Publicado: (2011)

Safety aspects and rational use of a naproxen + esomeprazole combination in the treatment of rheumatoid disease
por: Roberts, David N, et al.
Publicado: (2011)

Crystallization of Esomeprazole Magnesium Water/Butanol Solvate
por: Skieneh, Jenna, et al.
Publicado: (2016)

Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography–tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole
por: Dionísio, Thiago José, et al.
Publicado: (2020)

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
por: Rostom, Alaa, et al.
Publicado: (2009)

Relative Value of the NSAIDs, Including COX-2 Inhibitors and Meloxicam
por: Curtiss, Frederic R.
Publicado: (2006)

Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazol—Results
por: Oliveira, Gabriela Moraes, et al.
Publicado: (2022)

Development and Validation of Simple Titrimetric Method for the Determination of Magnesium Content in Esomeprazole Magnesium
por: Haddadin, R. N., et al.
Publicado: (2011)

Novel Esomeprazole Magnesium-Loaded Dual-Release Mini-Tablet Polycap: Formulation, Optimization, Characterization, and In Vivo Evaluation in Beagle Dogs
por: Kwon, Taek Kwan, et al.
Publicado: (2022)

The impact of viscosity on the dissolution of naproxen immediate-release tablets
por: Hassan, Dastan Salim, et al.
Publicado: (2022)

NSAIDs Naproxen, Ibuprofen, Salicylate, and Aspirin Inhibit TRPM7 Channels by Cytosolic Acidification
por: Chokshi, Rikki, et al.
Publicado: (2021)

Biological Evaluation of Naproxen–Dehydrodipeptide Conjugates with Self-Hydrogelation Capacity as Dual LOX/COX Inhibitors
por: Moreira, Rute, et al.
Publicado: (2020)

Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
por: Ding, Ying, et al.
Publicado: (2023)

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
por: Israr, Muhammad, et al.
Publicado: (2022)

Efficacy of naproxen with or without esomeprazole for pain and inflammation in patients after bilateral third molar extractions: A double blinded crossover study
por: Weckwerth, Giovana M., et al.
Publicado: (2017)

Complexity in Estimation of Esomeprazole and its Related Impurities’ Stability in Various Stress Conditions in Low-Dose Aspirin and Esomeprazole Magnesium Capsules
por: Reddy, Palavai Sripal, et al.
Publicado: (2013)

Selective COX-2 inhibitors, NSAIDs and cardiovascular events – is celecoxib the safest choice?
por: Howes, Laurence Guy
Publicado: (2007)

Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance
por: Borer, Jeffrey S, et al.
Publicado: (2005)

A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis
por: Lovell, Daniel J., et al.
Publicado: (2018)

Factors Affecting Quality of Life and Satisfaction in Patients with Arthritis after Change to a Fixed-Dose Naproxen/Esomeprazole Combination Drug
por: Park, Daehyun, et al.
Publicado: (2020)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
por: Terrier, Olivier, et al.
Publicado: (2021)

Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
por: Ding, Ying, et al.
Publicado: (2023)

Efficacy and safety of a fixed-dose combination of nimesulide/pantoprazole compared to naproxen/esomeprazole for pain relief in patients with osteoarticular diseases and dyspeptic symptoms
por: Scheinberg, Morton, et al.
Publicado: (2018)

A chemically modified solid-state sensor for magnesium(ii) ions and esomeprazole magnesium potentiometric assay
por: Saad, Ahmed S., et al.
Publicado: (2023)

Quantitative Estimation of Naproxen in Tablets Using Ibuprofen Sodium as Hydrotropic Agent
por: Maheshwari, R. K., et al.
Publicado: (2009)

Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs
por: Scheiman, James M, et al.
Publicado: (2005)

Bioequivalence of two esomeprazole magnesium enteric-coated formulations in healthy Chinese subjects
por: Liu, Zheng-Zhi, et al.
Publicado: (2020)

Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis
por: Hadi, Mohd Abdul, et al.
Publicado: (2016)

Selective COX-2 inhibitor continues to be a safe alternative in patients with nonselective NSAIDs hypersensitivity
por: Thalappil, Sherin, et al.
Publicado: (2022)

Bioequivalence of 2 Naproxen Sodium Tablet Formulations in Healthy Male and Female Volunteers
por: Sugár, Dalma, et al.
Publicado: (2019)

Antiproliferative Activity of Pt(IV) Conjugates Containing the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Ketoprofen and Naproxen †
por: Ravera, Mauro, et al.
Publicado: (2019)

Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease
por: de Alwis, Natasha, et al.
Publicado: (2022)

New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation
por: Bokhtia, Riham M., et al.
Publicado: (2023)

NSAIDs in sciatica (NIS): study protocol for an investigator-initiated multicentre, randomized placebo-controlled trial of naproxen in patients with sciatica
por: Grøvle, Lars, et al.
Publicado: (2022)

Formulation and roentgenographic studies of naproxen-pectin-based matrix tablets for colon drug delivery.
por: Rao, K. Purushotham, et al.
Publicado: (2003)

Pharmacokinetic Parameters Determination and In Vitro–In Vivo Correlation of Ileocolonic-Targeted pH-Responsive Coated Mini-Tablets of Naproxen
por: Hadi, Mohd Abdul, et al.
Publicado: (2015)

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk
por: Cheng, I, et al.
Publicado: (2007)

Gastrointestinal Bleeding Rates Among Managed Care Patients Newly Started on COX-2 Inhibitors or Nonselective NSAIDs
por: Stockl, Karen, et al.
Publicado: (2005)

Cost effectiveness of COX 2 selective inhibitors and traditional NSAIDs alone or in combination with a proton pump inhibitor for people with osteoarthritis
por: Latimer, Nicholas, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7i1mhiejvn0uu6plte2efft0il